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Abstract
Problem – Autism is a complex umbrella disorder given to children or adults who experience a
variety of similar symptoms, yet no concrete cause has been identified for those with the
diagnosis. Treatment options are expensive and complex, and no single method has been proven
effective for every child with autism. Some parents have utilized dietary intervention but existing
evidence on its effectiveness isn’t widely studied or recommended by practitioners.
Procedure – A literature review was conducted to determine the current evidence behind the
implementation of a gluten-free casein-free (GFCF) diet and its effectiveness on the severity of
symptoms associated with an autism diagnosis.
Results – Findings are not 100% consistent with a positive outcome of GFCF dietary
implementation in children with autism, yet 11 of the 15 studies examined did show
improvements in a variety of behaviors or physiologic processes.
Nursing Implications – Dissemination of findings to local pediatric practice offices and agencies
would prove beneficial with the encouragement of recommending a GFCF dietary trial for
children diagnosed with autism.
Introduction
It is currently estimated by the Centers for Disease Control and Prevention (CDC) that
one in 68 children are diagnosed with an autism spectrum disorder (ASD) (2016). Other sources
estimate this number to be even higher, at one in 50 children diagnosed (National Vaccine
Information Center, 2013). The autism prevalence rate among girls is approximately 1 in 189 and
unfortunately 5 times more likely in boys with a rate of 1 in 42 (CDC, 2016). Although this
number continues to increase, there is little known about the true etiologies or cures for the
disorder (Elder, 2008).
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The CDC (2016) defines ASDs as “a group of developmental disabilities that can cause
significant social, communication, and behavioral challenges.” Elder (2008) adds that children
living with an ASD diagnosis can present with repetitive behaviors and “processing delays that
can cause difficulties in responding to others, motor planning, and visual processing” (p. 584).
Genius and Bouchard (2010) also note significant symptoms to include “significant aggression,
tendencies toward self-injury and self-harm, irritability, as well as hyperactive and erratic
behavior” (p. 114).
The exact cause of ASD is unknown but there is belief that a genetic susceptibility to
environmental factors could play a major role. It is also hypothesized that immunologic and
gastrointestinal permeability play a role in the neurologic and behavioral symptoms associated
with autism (Mulloy et al, 2010). Many children with ASD will experience some form of chronic
constipation or diarrhea, suggestive of gastrointestinal disorder. Although there has not been a
proven cure, many studies are stating that removing both gluten and casein (a protein found in
cow’s milk) from the diet of children with autism can lead to a decrease in the severity of
symptoms associated with the disorder (Knivsberg, Reichelt, Hoien, & Nodland, 2002).
Purpose
Many children with autism will endure years and years of traditional therapy in attempts
to improve “typical” behavior and reduce symptoms related to their diagnosis (Hsu, Lin, Chen,
Wang, & Wong, 2009). The average cost of treatment for many individuals on the spectrum is an
outstanding $60,000-$70,000 PER YEAR for various therapies, schooling, and alternative
treatment options (Parker-Pope, 2010). Treatment recommendations generally include
educational intervention, physical and developmental therapy, and behavioral treatment (Elder,
2008). Yet “there is increasing recognition that the expression of ASD in some sub-groups may
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also include a number of additional elements beyond psychiatry that may be potentially relevant”
(Whiteley et al, 2010, p.88). Diet changes are under scrutiny as a physical trigger for
psychological symptoms. It is possible that dietary change can have a great impact on behavior
and therefore lessen the amount of therapy or other treatments necessary, yet this form of
alternative type therapy is not widely studied or utilized within the autism community.
Significance
Autism rates are soaring among children with a current estimate that one in every 50-68
children is diagnosed with an ASD. This is a 72% increase from 2007 when estimates were one
in every 88 children diagnosed (National Vaccine Information Center, 2013). “For some time
clinical experience has supported the existence of a functional relationship between the central
nervous system (CNS) and the gastrointestinal (GI) tract, a paradigm known as the ‘brain-gut
axis’” (Julio-Pieper, Bravo, Aliaga, & Gotteland, 2014, p. 1188). “The first ever formal
description of autistic symptoms contains reference to GI symptoms and dietary issues being
present in some cases” (Whiteley et al, 2013, p. 2).
The intestinal mucosa is the largest surface of interaction between internal body systems
and the external environment. It’s dual functions include regulation of the absorption of water,
electrolytes, and nutrients from the intestines into circulation, while at the same time preventing
the penetration of harmful pathogens and toxins, including dietary antigens (Julio-Pieper et al,
2014). The theory behind the removal of gluten and casein of a child with autism’s diet involves
the belief that children with autism cannot break down the gluten and casein proteins completely
or appropriately. This inappropriate breakdown results in opioid peptides that are able to leak
through the intestinal wall (leaky gut syndrome), enter the bloodstream, cross the blood-brain
barrier, and ultimately affect neurotransmission within the central nervous system (Elder, 2008).
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Studies have shown that many children with autism suffer from gastrointestinal inflammation
due to the ingestion of these proteins, which eventually leads to the leaky gut syndrome that
allows the peptides to enter the bloodstream (Knivsberg et al, 2002).
The impaired neurotransmission in children with autism, as a result of ingesting gluten
and/or casein products, is believed to attribute to difficulties in communication and use of
language, affect attention and concentration, impair social integration and interaction, contribute
to altered pain perception and lead to self-injurious behaviors, contribute to stereotypical or
repetitive behaviors, impair motor coordination, and contribute to hyperactivity (Whiteley et al.,
2013). Therefore, it is possible that removing these proteins from the diet of a child with autism
could lead to an improvement or elimination of some or all of his or her symptoms.
Theoretical Framework
The framework for this study is based upon a physiological theory known as the leaky
gut hypothesis, which correlates poor gut health and function to neurological symptoms
specifically in children with an ASD (Lang, Hauser, & Reissmann, 2015). Oftentimes, children
with autism will exhibit a variety of gastrointestinal disturbances. These may include one or all
of the following: constipation, diarrhea, abdominal pain and/or abdominal bloating. Some
parents’ even report that these symptoms began around the same time their child regressed and
began experiencing autism symptoms (White, 2003).
The “GI tract works very closely with the immune system to maintain homeostasis and
protects our body against microorganisms and foreign antigens” (Samsam, Ahangari, & Naser,
2014, p. 9944). The intestinal lumen is lined by only a single layer of epithelial cells, which are
responsible for preventing various intestinal contents from escaping the gut and entering the
bloodstream. These epithelial cells are joined together by filaments forming tightly bound
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intercellular junctions on their lateral walls (Liu, Li, & Neu, 2005). “The idea that the integrity of
the intestinal mucosal lining, referred to as the intestinal mucosal barrier, is compromised in
autism is embodied in the ‘leaky gut hypothesis.’ According to this hypothesis, the intestinal
mucosa is abnormally permeable in autism” (White, 2003, p. 642). In other words, the junctions
between the epithelial cells are compromised and are unable to properly regulate what may enter
and escape the intestinal lumen.
The exact cause of this intestinal dysfunction isn’t clearly known but speculations have
been made on a few different causes. One possible cause of intestinal inflammation and
dysfunction seen in children with autism, and the primary focus of this project, is due to antigens
in the diet. Gliadin is the peptide that is derived from gluten and is believed to cause or
contribute to increased intestinal permeability the same way it affects those with Celiac Disease.
Similarly, “children with cow’s milk allergy also exhibit inflammation of the intestinal lamina
propria and partial villous atrophy after ingesting milk; inflammation is reversed when milk is
excluded from the diet. Hence, milk proteins may also cause changes in gut permeability”
(White, 2003, p. 643).
According to the leaky gut hypothesis, “it is proposed that gliadomorphins and
casomorphins arising from the partial luminal digestion of dietary gliadin and casein,
respectively, are absorbed through a leaky gut, enter into the CNS, and interfere with normal
brain function because their functional properties mimic the opioid hormone beta-endorphin”
(White, 2003, p. 646). Petra et al (2015, p. 985) also support this idea stating, “Neuro/immuneactive substances derived from the intestinal lumen can penetrate the gut mucosa, be transported
by blood, cross the blood–brain barrier (BBB), and affect the CNS.”
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“GI abnormalities are often seen to correlate with the severity of the ASD behavioral
problems and current literature favors a gut-brain interaction where GI abnormalities may be
involved in the pathogenesis or severity of ASD” (Samsam et al, 2014, p. 9944). Due to this
hypothesis, a diet free from the gluten and casein proteins is recommended to alleviate GI as well
as neurologic or behavioral symptoms.
Definitions
Autism Spectrum Disorder (ASD) – “Autism spectrum disorder (ASD) and autism are both
general terms for a group of complex disorders of brain development. These disorders are
characterized, in varying degrees, by difficulties in social interaction, verbal and nonverbal
communication and repetitive behaviors” (Autism Speaks, 2016).
Casein – a phosphoprotein of mammal milk (Merriam-Webster, 2015).
Celiac Disease – “an autoimmune disorder that can occur in genetically predisposed people
where the ingestion of gluten leads to damage in the small intestine” (Celiac Disease Foundation,
2016).
Gluten – “a tenacious elastic protein substance especially of wheat flour that gives cohesiveness
to dough” (Merriam-Webster, 2015).
Lamina Propria – “a highly vascular layer of connective tissue under the basement membrane
lining a layer of epithelium” (Merriam-Webster, n.d.).
Leaky-Gut Syndrome – Impaired intestinal permeability leading to abnormal intestinal absorption
(Pusponegoro, Ismael, Firmansyah, Sastroasmoro, & Vandenplas, 2015).
Opioid – “Any of a group of endogenous neural polypeptides (as an endorphin or enkephalin)
that bind especially to opiate receptors and mimic some of the pharmacological properties of
opiates —called also opioid peptide” (Merriam-Webster, 2015).
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Peptide – “Any of various amides that are derived from two or more amino acids by combination
of the amino group of one acid with the carboxyl group of another and are usually obtained by
partial hydrolysis of proteins” (Merriam-Webster, 2015).
Process
The University of North Dakota’s Harley E. French Library of the Health Sciences was
used to conduct a search of related literature. The CINAHL database was the initial database
used when performing the search. According to the EBSCOhost website, CINAHL provides
“hundreds of nursing and allied health journals” with “records dating back to 1937” (EBSCO
Industries, 2013). PubMed was used as a secondary source of information. “PubMed is a free
resource that is developed and maintained by the National Center for Biotechnology Information
(NCBI), at the U.S. National Library of Medicine (NLM), located at the National Institutes of
Health (NIH)” (NCBI, 2005).
When conducting the search in the CINAHL database the terms “autism” AND “gluten”
AND “casein” were entered with the “find all my search terms” used as the search mode. This
yielded 22 results found with publication dating back to the year 2000. After a brief overview,
eight articles were reviewed in more detail and only two articles were found to be relevant to the
project topic. A second search term was performed with the terms “gfcf autism.” This search
revealed five results, four of which were included in the original search. The fifth article was
reviewed in detail and determined to be pertinent to the project topic.
Another search was conducted through the PubMed database with the search term “gfcf
autism” which yielded six results. Three articles were reviewed in detail and it was determined
that only one was relevant. Subsequently the terms “autism and gluten and casein” were entered
into the search field. This search yielded 53 results, seven of which were reviewed in detail and
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three additional were determined to be relevant. A third search was entered into the PubMed
database with the search term “gluten autism” which yielded 115 results. Thirteen articles were
reviewed in detail and it was determined that eight articles were relevant, which concluded the
search.
Article reference sections for both database searches were reviewed prior to making the
final determination of relevant articles. It was found that references that appeared relevant had
already been included in the original search results; therefore additional sources from references
were not utilized.
Review of the Literature
Specific studies regarding the elimination of gluten and casein from an autistic child’s
diet are limited and many are now outdated. Fifteen studies were examined in detail with varying
results. Many different symptoms were measured and varied from study to study. Some of these
included communication, social isolation, eye contact, mutism, learning skills, hyperactivity,
stereotypical activity, hygiene, panic attacks, self mutilation, gastrointestinal problems, social
interaction, imagination, tantrums, anxiety, seizure activity, inattention, aloofness, need for
routine, peer relationships, empathy, physical contact, language peculiarities, peculiar interests,
sensory symptoms, and motor skills.
Four of the studies examined were case reports on a single child ranging in ages from
three, to 23 years old and detailed his or her history and symptom improvement or resolution
following a gluten-free or gluten and casein-free diet (Hsu, Lin, Chen, Wang, & Wong, 2009;
Genius & Lobo, 2014; Herbert & Buckley, 2013; Genius & Bouchard, 2010). All four of the
children described in these articles experienced positive improvements in autistic behaviors or
complete resolution of symptoms leading to a complete recovery.
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Hsu et al (2009) followed one child aged 42 months at the initiation of the study who was
diagnosed with autism, growth and developmental retardation, and CHARGE (Coloboma of the
eye, Heart defects, Atresia of the choanae, Retardation of growth and/or development, Genital
and/or urinary abnormalities, and Ear abnormalities and deafness) syndrome. The child was
observed over an 11-month time span and data was collected throughout that time frame.
Improvements in all areas of development were noted at the 11-month mark of follow-up.
Weight percentiles were also measured, which were originally below the third percentile and had
increased to approximately the 15th percentile by that time. Strengths of this article included the
fact that objective developmental measurement tools were utilized before and after dietary
intervention and included intermittent follow-up periods. Also, the length of time for follow up
was significant, allowing for complete healing of the gastrointestinal system if gluten and/or
casein proved a causative factor. Limitations included the fact that this was just a single observed
case report and double blind observations before and after initiation of diet were not performed.
Also, the child continued to receive physical, occupational, speech, and sensory integration
therapies throughout dietary intervention, which could also have an effect on the final outcome.
Genius and Lobo (2014) reported on a now 23-year-old female with a longstanding
history of auditory and visual hallucinations, along with gastrointestinal disturbances, which all
began around the age of four or five. The subject experienced extreme auditory and visual
hallucinations throughout her entire life as well as being diagnosed with irritable bowel
syndrome. Her parents never sought medical treatment or medication for her symptoms but she
did participate in some religious counseling. By the time she entered college and after other
unsuccessful dietary elimination trials, she decided to independently eliminate gluten from her
diet. This resulted in complete resolution of her symptoms. Hallucinations would return within
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hours of any slight accidental gluten exposure and last 24-72hrs, giving her a clear indication of
a definitive correlation between gluten ingestion and her neurologic symptoms. Strengths of this
article included the fact that symptoms completely resolved after gluten elimination without any
other intervention, providing a clear correlation. Also this subject was not diagnosed with autistic
disorder or any other learning disability and was able to give an accurate description and detail of
her symptoms. Limitations included the fact that there wasn’t any concrete laboratory data
utilized as subject refused, given that her symptoms completely resolved and she didn’t find it
necessary. It was not mentioned whether physician monitoring was present.
Herbert & Buckley (2013) described a young girl, now aged 13, who had been
developing typically up until the age of four when she went into her pediatrician’s office for a
well-child checkup. The article states that after that visit the girl unfortunately experienced
severe, regressive autism and reverted back to an 18-month level of language and development.
Her parents had attempted various treatment options with very limited success before starting her
on a GFCF diet. After diet implementation she had showed a significant improvement in autistic
behaviors. Over a period of several years her Childhood Autism Rating Score (CARS) decreased
from an initial score of 49, representing severe autism, down to a score of 17, which represents
non-autistic behaviors. During puberty the girl also began to experience seizure activity, which
her parents negated with a GFCF ketogenic diet. Both dietary interventions provide evidence and
hope that there is a possible correlation between diet and neurologic symptoms. Strengths of this
article included the fact that symptoms and interventions are detailed chronologically providing a
clear understanding of the sequence of events. Also an EEG was performed pre and post
ketogenic dietary intervention to show concrete evidence of diminished seizure activity with no
other changes in treatment plan. Limitations included the fact that the cause of significant
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regression into autism in a previously neurotypical 4-year-old is not mentioned. Also, other
biomedical treatments and supplements were being utilized and changed throughout her years of
treatment. Lastly, the source of information was not mentioned.
Genius and Bouchard (2010) provided a description of a 5-year-old boy who was
diagnosed with severe autism at the age of three, who also experienced multiple abnormal GI
symptoms. Through laboratory testing the child was eventually diagnosed with Celiac Disease. A
gluten-free diet was implemented along with dietary and supplemental measures. After just 3
short months, the child could be mainstreamed back into a regular education classroom without
any individualized special education plan and his autism symptoms completely disappeared.
Strengths of this article included the fact that concrete laboratory data was utilized to make a
formal diagnosis of Celiac Disease. Limitations would be that follow up biochemical nutritional
testing was declined by his parents due to a complete resolution of symptoms and the source of
information is unknown.
Two cohort studies were reviewed (Pennesi & Klein, 2012; Cade, Privette, Fregly,
Rowland, Sun, Zele, Wagemaker, & Edelstein, 2000) which also showed improvements in
autistic behavior and laboratory values after implementation of a GFCF diet.
Pennesi & Klein (2012) conducted a survey for the parents of 387 children diagnosed
with an ASD who were already following a GFCF diet to some degree. The study aimed to
evaluate whether the implementation of a GFCF diet resulted in improvements in autistic
behaviors, social behaviors, and GI symptoms. A 90 item online questionnaire was administered
to each of the 387 parent participants. Diet implementation, compliance, and length of
implementation were measured. Also included were parental reports of observable changes in
their child’s behaviors as well as GI symptoms. Results show that implementing a GFCF diet
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may positively impact autistic behaviors and GI symptoms, specifically for those with previous
GI symptoms and food allergies reported (p<0.05). Strict adherence seems to have a better
outcome than those who have dietary errors even just on occasion. Strengths of this study
included the fact that explanation of the purpose was clear, there was a large sample size, and
participants were grouped by specific diagnosis as well as diet adherence. Limitations included
the fact that there weren’t any exclusion criteria for participants and there weren’t any control
methods regarding diet implementation. Also the survey was subjective and responses could vary
a great deal with each participant.
Cade et al (2000) also conducted a cohort study to determine whether the consumption of
gluten and casein results in an abnormally high level of peptides in the urine and blood of
schizophrenic adults and autistic children. The subjects included 83 schizophrenic men (age 1749), 37 schizophrenic women (ages 18-46), 128 autistic boys (ages 3.5-16), and 22 autistic girls
(ages 3.5-14). Participants met DSM III criteria for his or her diagnosis. Laboratory data was
collected from each subject and the same data was collected on control subjects who met similar
age and sex characteristics. Data was collected on all subjects pre-intervention, at one month and
three months after dietary intervention. Findings showed that 81% of the autistic children
showed improvements in laboratory findings after three months of dietary intervention. Nineteen
percent showed findings consistent with dietary error and continued gluten and casein
consumption. Improvement was also noted after three months in the following behaviors: social
isolation, eye contact, mutism, learning skills, hyperactivity, stereotypical activity, hygiene,
panic attacks, and self mutilation. Strengths included the use of concrete laboratory findings and
large sample sizes. Limitations were the short duration of dietary intervention and the fact that
there wasn’t a control group consisting of individuals who also carried a similar diagnosis.
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Seung, Rogalski, Shankar, & Elder (2007) conducted a randomized, double blind
crossover study to examine the effectiveness of a GFCF diet in children with ASDs in relation to
verbal and nonverbal communication. Thirteen children (10 male and three female) between the
ages two and 16 who had been diagnosed with autism participated. Diagnosis was based on the
DSM-IV criteria for ASD. Videos of parent-child play interactions were used. Verbal exchanges
were measured using the Systematic Analysis of Language Transcripts (SALT) and
communication behaviors were analyzed using nonparametric (Friedman) tests. Results were as
follows: Verbal social exchanges had means to include a baseline=16, GFCF=11, and regular
diet=15; verbal imitations had means to include a baseline=3.85, GFCF=1.85, and regular
diet=3.54; number of words produced had means to include a baseline=35, GFCF=32, and
regular diet=37; and total utterances had means to include a baseline=42, GFCF=36, and regular
diet=45. Strengths of the study included the fact that it is a double blind randomized clinical trial
and food was prepared by one certified nutritionist for all participants. Limitations included a
short intervention period, small sample size, and there was a large variance between baseline
verbal abilities. Also this was a secondary analysis using existing data.
Knivsberg, Reichelt, Hoien, & Nodland (2002) conducted a single blind, randomized
study to determine whether a GFCF diet may aid in enhanced learning for children diagnosed
with autistic syndromes. They examined social, emotional, attention, communication, cognitive,
sensory, and motor skills using standardized testing before and one year after diet
implementation. A control group was utilized. Subjects included 20 children with autistic
syndromes as well as abnormal urinary peptide patterns. Ages ranged from 59-127 months. Ten
children were placed in the control group and 10 children utilized dietary intervention. The
DIPAB (a Danish instrument for measuring autistic traits) was utilized to evaluate autistic
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behavior, function of language, motor skills, communication, and social contact. Cognitive skills
were measured using the Leiter International Performance Scale. Linguistic abilities were
measured using the Illinois Test of Psycholinguistic Abilities and the Reynell Developmental
Language Scale. Lastly, motor function was measured using the Movement Assessment Battery
for Children. Many specific traits were examined based on the general behaviors of autism listed
and every single trait showed marked improvement in the diet group when compared to the
control group after one year of implementation. Strengths included a randomized, single blind
study with a long implementation period. Inclusion criteria were utilized and educators were
made available to parents throughout the study. Limitations on this study were that the sample
size utilized was fairly small and it’s possible the study could have been double blinded.
Whiteley et al (2010) conducted a two stage, 24 month, scanbrit randomized, controlled,
single-blind study of a GFCF dietary intervention for children with autism spectrum disorders to
evaluate and compare the effects of dietary interventions between a control and intervention
group using a comprehensive assessment battery in children diagnosed with ASDs. The
participants included 55 children with an ASD diagnosis. There were 26 children in the
intervention group and 29 in the control group. Exclusion criteria for the study included any comorbid diagnoses of epilepsy, fragile-X syndrome, tuberous sclerosis, developmental age below
24 months, or the use of pharmacologic therapy. Autism behaviors were assessed using the
Autism Diagnostic Observation Schedule (ADOS) and Gilliam Autism Rating Scale (GARS).
Developmental level was assessed using Vineland Adaptive Behavior Scale (VABS). Study
members were blinded, but the parents were not blinded. Reassessments were performed at 8 and
12 months. The control group was then also placed on a GFCF diet from 12-24 months and
reassessed. Improvement was seen after 12 months in core autistic behaviors for the intervention
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group with ADOS P=0.0022, GARS P=0.0001, as well as improvements in inattention and
hyperactivity. There was a plateau effect thereafter. Strengths of this study included the fact that
exclusion criteria were utilized, the study took place over a sufficient amount of time to truly see
changes, and study participants were blinded. Limitations included the fact that the study was not
double blinded, children continued to receive alternative therapies, and the study was unable to
identify potential best responders based on their history or characteristics.
Elder, Shankar, Shuster, Theriaque, Burns, & Sherrill (2006) conducted a randomized,
double-blind repeated measures crossover design pilot study to determine the effects of a GFCF
diet on the behaviors of autistic children and evaluate the effects of dietary intervention on
urinary peptide levels. 15 children (12 boys and 3 girls), ages 2-16 with ASD were included in
the study. Tools used to measure subject qualities included the Autism Diagnostic InterviewRevised (ADI-R), the Childhood Autism Rating Scale (CARS), Urinary Peptide Levels (UPL),
and the Ecologic Communication Orientation (ECO) Language Sampling Summary. Data was
collected prior to intervention, at week 6, and at week 12. Unfortunately, no significant changes
were noted over the 12-week trial period. CARS p= .85, ECOS p= .29, behavioral frequencies
.32 < p < .45, urinary peptide levels of gluten p= .44 and casein p= .11. Strengths included the
fact that this was a randomized, double blind study and a placebo diet was used to keep parents
blinded. Limitations included the small sample size used, the short duration of only 12 weeks,
and the fact that dietary intervention was not performed in a controlled environment.
More recently, in 2015, two randomized double blind placebo controlled studies were
performed although both studies lasted only a short period of time and did not produce positive
results. One of the studies lasted only 7 days, which seems fairly pointless to even conduct, and
the second lasted 12 weeks. The results are as follows.
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The first study was conducted by Pusponegoro, Ismael, Firmansyah, Sastroasmoro, &
Vandenplas (2015) to determine the effect of gluten and casein supplementation in children, who
were previously GFCF, on maladaptive behavior, gastrointestinal symptom severity, and urinary
I-FABP (intestinal fatty acid binding protein) excretion which is a marker for intestinal mucosal
cell damage. Fifty children, ages 4.3-6.7 with ASD, who had severe maladaptive behavior and a
urinary I-FABP value of > 96.97pg/mg creatinine, were included in the study. The Approach
Withdraw Problems Composite (AWPC) was used to measure maladaptive behaviors pre and
post gluten and casein exposure, the Gastrointestinal Symptom Severity Index (GSSI) was used
to measure GI symptoms pre and post exposure, and Urinary I-FABP was measured pre and post
exposure. The AWPC t-score decreased after supplementation in the placebo (p < 0.001) and
intervention groups (p < 0.001). P=0.971 between the two groups. Both groups started with a
GSSI of zero. After intervention, the median GSSI for the control group was 0 and median for
the intervention group was 3. There was an increasing trend of I-FABP in the intervention group
and a decreasing trend in the control group, yet changes between the two groups were not
significantly different with p=0.416. The only strength noted for this study is that it was a
randomized double-blind study. A fair number of limitations were noted that included a small
sample size, short duration of gluten/casein consumption, the biscuits utilized as gluten/casein
supplementation were probably not identical in taste, the chosen amount supplemented was
arbitrary, the time between inclusion in study and introduction of dietary intervention varied, and
outside therapies differed and were not considered for each child.
The second recent study was conducted by Hyman et al (2015) to obtain information on
the safety and efficacy of the GFCF diet in children with autism. This was a 12-week double
blind, placebo-controlled challenge study that included 14 children who were under the age of
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six and diagnosed with Autistic Disorder, Asperger’s Disorder, or Pervasive Developmental
Disorder Not Otherwise Specified based on the criteria from the DSM-IV. Participants were
required to be enrolled in a comprehensive Applied Behavior Analysis Intervention program for
the duration of the study. Multiple scales and scoring methods were utilized to include: Autism
Diagnostic Interview (ADI-R), Autism Diagnostic Observation Schedule (ADOS), Mullen
Scales of Early Learning, Vineland Adaptive Behavior Scales, World Health Organization
growth standards, laboratory testing for food allergies and vitamin deficiencies, the Bristol Stool
Scale, the Conners Abbreviated Rating Scale, and the Ritvo-Freeman Real Life Rating Scales.
Unfortunately, no significant findings were noted on active challenge days when compared to
placebo challenge days. There are some notable strengths and weaknesses of this study.
Strengths included the utilization of Registered Dieticians to monitor adherence to diet and
nutritional intake, the fact that consumption of gluten and casein was carefully measured, there
was consistency in all the children receiving Applied Behavior Analysis (ABA) therapy, and
everyone was blinded to the challenges given. Limitations included the small sample size, the
fact that only a 4-6 week complete GFCF diet was required prior to the challenges which may be
too short to see initial changes, and the fact that administering gluten and/or casein challenges
would seem to defeat the purpose of long term GFCF dietary intervention.
Harris & Card (2012) conducted a cross-sectional pilot study to evaluate the nutritional
influences on GI symptoms and behavior patterns in children with ASD. Participants included 13
children, aged 5-12 years old diagnosed with an ASD, who were recruited from the Asperger’s
Support Network website. An online survey was conducted which included questions regarding
general health, demographics, GI symptoms, behavior patterns, and a Food Frequency
Questionnaire (FFQ). Gastrointestinal Symptoms Rating Scale (GSRS) was used to rate
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abnormal GI symptoms, and the Childhood Autism Rating Scale (CARS) was used to rate
behavior patterns. More than half of the children were already on a GFCF diet by parental
choice. 53.8% of the children did experience postprandial GI symptoms according to the survey.
Mean GSRS score was 19.2 and mean CARS score was 43.9 and unfortunately scores did not
differ according to diet. However, 100% of the parents with children on a GFCF diet (n=7)
reported improved GI and behavior patterns after diet implementation. A couple strengths for
this study included the use of validated questionnaires and relative homogeneity of the sample.
Limitations included the small sample size, the fact that the questionnaires were subjective, the
uncertain ability of parents to quantify the severity of their child’s symptoms, and the differences
in parental implementation of the GFCF diet.
A more unique approach to studying dietary effects on children with ASD was conducted
by de Magistris et al (2013) to challenge the hypothesis that dietary-derived non-self antigens
could permeate impaired gut barrier and stimulate the immune system, affecting or increasing
autism symptoms. Participants included 31 children with an ASD diagnosis currently following a
GFCF diet for an average of 3 years, 131 children with an ASD diagnosis following a regular
diet, and 44 healthy children utilized as matched controls. Data collected included intestinal
permeability measurements and antibodies to food antigens. A statistical analysis was performed
using the Mann-Whitney, the Kruskal-Wallis and Dunn’s, and Fisher exact tests. Approximately
twenty five percent of the enrolled ASD children had impaired intestinal barrier function. The
GFCF diet appeared to normalize intestinal barrier impairment. Immune response was noted to
be triggered by gluten and casein consumption in some ASD children. It is probable that
determination of antibody titers to food antigens could be used to identify potential responders to
the GFCF diet according to the study. Strengths of this study included the large sample size of
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ASD children, the fact that control groups were present, and concrete laboratory evidence was
utilized. Limitations included a smaller control group when compared to the study group, the fact
that dietary intervention was not professionally monitored, and autism behavior symptoms
specifically were not evaluated.
One last and the most recent case-control study that was examined was conducted by
Mari-Bauset, Llopis-Gonzalez, Zazpe, Mari-Sanchis & Suarez-Varela (2016) to determine
whether children with ASD on a GFCF diet vs. a regular diet have lower anthropometric
measures, varied nutrient intake, and are less likely to meet daily-recommended intake values.
Children ages 6-9 years old diagnosed with an ASD were enrolled in the study and the severity
of autism symptoms was not considered (n=105). The study group consisted of 20 children and
the control group consisted of 85 children. Height and weight measurements were utilized to
calculate BMI. Caloric intake, macronutrients, and micronutrients were compared between the
two groups. The Healthy Eating Index was utilized also to compare nutrients and Dietary
Reference Intakes were utilized to measure adequate or inadequate intake. Overall, ASD children
on a GFCF diet had lower BMI’s than those on a regular diet. Vitamin and nutrient differences
were noted between the two diets with the GFCF group being deficient in some nutrients but the
regular diet group experienced deficiencies in other nutrients. Typically the GFCF diet group ate
a “healthier” diet than their counterparts. Strengths included the children presented with similar
characteristics in socioeconomic status, place of residence, ethnicity, and living conditions and
the children were studied in parallel over the same time period. Limitations included a small
sample size, the fact that only a 3-day food record was utilized, the GFCF diet was not monitored
professionally, and autism behaviors or characteristics were not mentioned in this study.
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Articles were reviewed and graded using the American Association of Critical-Care
Nurses’ (AACN) updated evidence-leveling system, which was revised in 2008. This upgraded
system helps to alleviate confusion when compared to other grading systems, as the order of
grading had originally been reversed compared to others. “Research designs identified in the new
leveling system include meta-analysis, meta-synthesis (the qualitative counterpart to metaanalysis), randomized and nonrandomized studies, qualitative research, descriptive or
correlational studies, systematic reviews, and integrative reviews” (Armola et al, 2009).
This grading system uses an alphabetical instead of numerical scale to further minimize
confusion when compared with other systems. Letters range from A to M: A being the highest
level of evidence to include meta-analyses and meta-syntheses with consistent results, and M
referring to manufacturer’s recommendations only (Armola et al, 2009). This grading system
was chosen due to the broad range of description for hierarchy and the variability of the 15
studies examined. A synopsis of each study with its individual level of hierarchy grade can be
found in the Appendix.
Discussion
Dissemination
Background information and theory as well as a summary of findings via poster was
presented to a local pediatrician’s office to encourage practicing physicians to include dietary
recommendations in the care and treatment of children with an ASD. The poster was utilized
since it was unlikely that the small family practice had the resources or space available to
conduct a PowerPoint presentation. Time was allotted for discussion at the end of the
presentation to answer questions and obtain opinions and feedback from the physicians and
office staff. Finally, an anonymous survey was conducted to determine whether the physicians
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and staff found the information useful and to determine whether they saw it plausible to include
dietary recommendations in their treatment plans proceeding forward.
Three physicians, one physician’s assistant, and two registered nurses were present for
the presentation. Overall, the staff was not aware of dietary intervention for children with an
ASD other than in cases where a true dietary allergy was present. The physicians and physician’s
assistant were skeptical to agree upon immediately recommending a GFCF diet to their patients.
They did agree, however, to perform some more research independently in order to gain a
broader understanding of dietary implications in children with an ASD. All agreed that they
might possibly begin making the recommendation to parents in the future, so long as the parent
understands that positive results are not guaranteed.
Interpretation
Eleven out of the 15 studies did show improvements in the symptoms being measured
after eliminating gluten and casein from the subjects’ diet (Hsu et al, 2009; Pennesi & Klein,
2012; Knivsberg et al, 2002; Whiteley et al, 2010; Cade et al, 2000; Harris & Card, 2012; de
Magistris et al, 2013; Mari-Bauset et al, 2016; Genius & Lobo, 2014; Herbert & Buckley, 2013;
Genius & Bouchard, 2010). The four studies that showed no significant improvement (Seung et
al, 2007; Elder et al, 2006; Pusponegoro et al, 2015; Hyman et al, 2015) in any measured
symptoms had small sample sizes, short durations of diet implementation, or dietary infractions
as part of the study. Overall, better results had been reported after completing one full year of
dietary intervention in the studies lasting that length of time (Cade et al, 2000; Hsu et al, 2009;
Knivsberg et al, 2002; Whiteley et al, 2010; de Magistris et al, 2013; Genius & Lobo, 2014;
Herbert & Buckley, 2013).
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Many of these studies seem flawed in one way or another. A common theme among all of
the studies is the difficulty in knowing whether strict adherence to the GFCF diet was successful
without mistake, since all of the studies allowed the children to remain in their own home and
continue with life as usual otherwise.
It would make sense that long term dietary change would need to take place in order to
see major changes in neurologic or behavioral symptoms. Just as any other part of the human
body, if damage has occurred to the GI tract due to the consumption of gluten or casein, it would
only seem reasonable that healing of the GI tract would take time after complete removal of
these proteins from the child’s diet has been successfully accomplished.
Implications for Nursing
Although the body of evidence for this literature review is not 100% consistent, it is not
without merit that the dietary intervention of removing gluten and casein from the autistic child’s
diet has the possibility of proving to be beneficial. Like any and every therapy or treatment for
ASD’s, a child may or may not respond positively to dietary intervention as children respond
differently to every treatment option currently available (Whiteley et al, 2013). It is important for
parents and physicians of children with autism to be aware of this possibility of gastrointestinal
inflammation and central nervous system correlation. The hope is that increased awareness will
lead to increased practice recommendations for dietary changes from practicing pediatricians to
the parents of children affected by ASD.
Based on the findings of this review, the first desired practice recommendation to be
made would be to disseminate findings and educate local developmental pediatric practices and
county developmental agencies of the possible benefits of following a GFCF diet as well as the
possible negative impact of gluten and/or casein consumption in autistic children. “Clinicians
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working with families of individuals with ASD are often asked for advice and find themselves
unable to offer the most up-to-date and scientifically credible information” (Elder, 2008, p.583).
The fact that there is even some hope and proof that a simple dietary change could alleviate
symptoms related to autism should be known by the clinicians that see and treat these children on
a daily basis.
The American Family Physician (AFP) Strength of Recommendation Taxonomy (SORT)
was utilized to review this recommendation. According to this system, “grades are assigned on
the basis of quality and consistency of available evidence” (Ebell et al, 2004). This scale is
intended to allow its use among various sources of evidence and is currently used by several
medical journals. Recommendations are given a grade A, B, or C. The above recommendation is
given a grade B for overall strength since results are inconsistent and studies are limited.
The second recommendation proposed would be to encourage these developmental
pediatricians and local developmental agencies to include dietary change as a possible treatment
option for children diagnosed with an ASD. Treatment recommendations generally include
educational intervention, physical and developmental therapy, and behavioral treatment (Elder,
2008). Yet “there is increasing recognition that the expression of ASD in some sub-groups may
also include a number of additional elements beyond psychiatry that may be potentially relevant”
(Whiteley et al, 2010, p.88). Diet changes are under scrutiny as a physical trigger for
psychological symptoms. The hypothesis that eliminating gluten and casein consumption proves
beneficial in some way has been strengthened by the results of 11 of the 15 studies examined. It
would only seem fair to offer desperate parents seeking answers any and every angle of
treatment that is available to possibly benefit their children.
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This practice recommendation is also given the strength of recommendation grade B
using the SORT hierarchy due to the inconsistency of results and limited availability of evidence.
It is important to note however, that every single autistic child is unique and no two are exactly
alike. The diagnosis is termed autism spectrum disorder because there is an extremely large
“spectrum” of symptoms that may be seen from child to child (Pennesi & Klein, 2012).
Therefore, it is impossible to determine that any treatment option, including diet, will 100% be
effective for all children diagnosed.
Implications for implementing the two proposed practice recommendations would be
finding the time and appropriate resources and personnel to travel to local physician offices and
developmental agencies. Also the reluctance of clinicians toward adopting new practice or
recommendations could prove to be a barrier toward successful implementation. It would prove
beneficial and probably more convincing for clinicians, if further research including larger
sample sizes and longer duration paired with better control over interventions was conducted.
It is my hope that upon completion of my Master’s in Nursing Education degree, I will be
able to work directly with physicians who treat children with autism as well as educate the
parents and families who are caring for these children. I hope to bring an increased awareness of
alternative treatment options, including the GFCF diet, as well as conventional treatment options
to the parents of children with autism.
Conclusion
Although the topic of dietary intervention for children with ASD seems to be growing,
scientific information and evidence is still extremely limited. Studies vary in their methods,
measurements, and results. Recommendations for future studies would include adequate control
groups which mimic the intervention group, larger sample sizes overall, longer durations of
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complete gluten and casein removal from the diet, and more concrete symptom measurement and
evaluation versus parental input.
It is interesting and reassuring to know that there are new and alternative treatments being
addressed for the growing number of autistic children present in our country today. Many parents
are unsatisfied with current diagnosis standards and traditional treatment options (White, 2003).
This may lead some to turn to many of the alternative treatments that are currently floating
around without full knowledge of whether or not they will work. Yet although current literature
is not fully supportive of the dietary removal of gluten and dairy as a guaranteed cure, current
results may leave parents, physicians, and therapists hopeful and lean toward a probable benefit
for many children.
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Authors
(Year)
Title
Publication
Pennesi, C.M.
& Klein, L.C.
(2012).
Effectiveness
of the glutenfree, caseinfree diet for
children
diagnosed
with autism
spectrum
disorder:
based on
parental
report.
Nutritional
Neuroscience
15(2), 85-91

Purpose

35
Design

To evaluate
Longitudinal
whether the
Survey
implementation Cohort Study
of a gluten and
casein free diet
results in
improvement in
autistic
behaviors, social
behaviors, and
GI symptoms in
children with an
autism spectrum
disorder (ASD)
diagnosis.

Sample

Data Collection
and
Measurement

Findings

Strengths and
Limitations

Level of
Evidence

N=387
participants
who were
parents or
primary
caregivers
of children
with a
clinical
diagnosis of
ASD. No
exclusion
criteria were
identified.

A 90 item online
questionnaire
was administered
to each
participant. Diet
implementation,
compliance, and
length of
implementation
was measured.
Also included
were parental
reports of
observable
changes in their
child’s behaviors
as well as
gastrointestinal
symptoms.

Results show
that
implementing
a gluten and
casein free
diet may
positively
impact autistic
behaviors and
GI symptoms,
specifically
for those with
previous GI
symptoms and
food allergies
reported
(p<0.05).
Strict
adherence
seems to have
a better
outcome than
those who
have dietary
errors even
just on
occasion.

Strengths:
*Explanation of
the purpose was
clear.
*Large sample
size.
*Participants
were grouped by
specific
diagnosis as well
as diet
adherence.

AACN level
of evidence:
Grade C
(Cohort
Study with
inconsistent
results).

Limitations:
*No exclusion
criteria for
participants.
*Subjective
survey could
vary with each
participant.
*No control or
methods
regarding diet
implementation.
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Authors
(Year)
Title
Publication
Hsu, C.L.,
Lin, D.C.Y.,
Chen, C.L.,
Wang, C.M.,
& Wong,
A.M.K.
(2009).
The effects
of a gluten
and caseinfree diet in
children
with autism:
a case
report.
Chang Gung
Med J 32,
459-465.

Purpose

36

Design

To provide a
Observational
detailed report case-report
of one child
who showed
significant
improvements
in autistic
behaviors after
implementing a
gluten and
casein-free
diet.

Sample

Data Collection
and
Measurement

Findings

Strengths and
Limitations

Level of
Evidence

One child age
42 months at
the initiation of
the study,
diagnosed with
autism, growth
and
developmental
retardation, and
CHARGE
syndrome.

Data was
collected at 2.5
months, 5
months, and 11
months after
initiation of diet
implementation.
The Chinese
Child
Developmental
Inventory as well
as the Bayley
Scales of Infant
Development
were used to
classify
developmental
ages in eight
different areas of
growth and
development.

Improvement
in all areas of
development
were noted at
the 11 month
mark of follow
up as well as
weight
percentiles
which were
originally
below the third
percentile and
had increased
to
approximately
the 15th
percentile.

Strengths:
*Objective
developmental
measurement
tools were
utilized before
and after
interventions.
*Intermittent
follow up
periods.
*Long follow
up.
Limitations:

AACN level
of evidence:
Grade E
(single case
report and
no blindness
used for
evaluations).

*Single observed
case report.
*Double blind
observations
before and after
initiation of diet
were not
performed.
*Child continued
to receive
physical,
occupational,
speech, and
sensory
integration
therapies.
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Authors
(Year)
Title
Publication
Seung, H.,
Rogalski, Y.,
Shankar, M.,
& Elder, J.
(2007).

Purpose

To examine the
effectiveness of
a gluten and
casein free diet
in children with
autism
The glutenspectrum
and casein-free disorders in
diet and
relation to
autism:
verbal and
communicatio nonverbal
n outcomes
communication
from a
.
preliminary
double-blind
clinical trial.
Journal of
Medical
SpeechLanguage
Pathology
15(4), 337345.

37
Design

Sample

Data
Collection and
Measurement

Findings

Strengths
and
Limitations

Level of
Evidence

Randomized,
double-blind
crossover
design study.

Thirteen
children (10
male and three
female)
between the
ages two and
16 who had
been
diagnosed
with autism
participated.
Diagnosis was
based on the
DSM-IV
criteria for
autism
spectrum
disorder.

Videos of
parent-child
play
interactions
were used.
Verbal
exchanges were
measured using
the Systematic
Analysis of
Language
Transcripts
(SALT).
Communicatio
n behaviors
were analyzed
using
nonparametric
(Friedman)
tests.

Verbal social
exchanges:
Meanbaseline=16,
GFCF=11,
regular
diet=15.
Verbal
imitations:
Meanbaseline=3.85
, GFCF=1.85,
regular
diet=3.54.
Number
words
produced:
Meanbaseline=35,
GFCF=32,
regular
diet=37. Total
utterances:
Meanbaseline=42,
GFCF=36,
regular
diet=45.

Strengths:
*Randomized
clinical trial.
*Doubleblind.
*Food was
prepared by
one certified
nutritionist
for all
participants.

AACN
Level of
Evidence:
Grade B
(randomizeed doubleblind study
with
consistent
results).

Limitations:
*Short
intervention
period.
*Small sample
size.
*Large
variance
between
baseline verbal
abilities.
*A secondary
analysis using
existing data.
*No control
group used.
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Authors
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Title
Publication
Knivsberg,
K.M.,
Reichelt, K.L.,
Hoien, T., &
Nodland, M.
(2002).
A randomized,
controlled
study of
dietary
intervention in
autistic
syndromes.
Nutritional
Neuroscience
5(4), 251-261.
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Purpose

Design

Sample

Data
Collection and
Measurement

Findings

Strengths
and
Limitations

Level of
Evidence

To determine
whether a
gluten and
casein free diet
may aid in
enhanced
learning for
children
diagnosed with
autistic
syndromes.

Single blind,
randomized
study
examined
social,
emotional,
attention,
communicatio
n, cognitive,
sensory, and
motor skills
using
standardized
testing before
and one year
after diet
implementatio
n. Control
group was
utilized.

20 children
with autistic
syndromes as
well as
abnormal
urinary
peptide
patterns. Ages
ranged from
59-127
months. 10
children were
placed in the
control group
and 10
children
utilized dietary
intervention.

DIPAB
(standardized
Danish scheme)
utilized to
evaluate autistic
behavior,
function of
language, motor
skills,
communication,
and social
contact.
Cognitive skills
measured using
the Leiter
International
Performance
Scale. Linguistic
abilities
measured using
the Illinois Test
of
Psycholinguistic
Abilities and
Reynells
spraktest. Motor
function
measured using
Movement
Assessment
Battery for
Children.

Many specific
traits were
examined
based on the
general
behaviors of
autism listed.
Every single
trait showed
marked
improvement
in the diet
group when
compared to
the control
group after
one year.

Strengths:
*Long
implementation period.
*Randomized
, single blind
study.
*Inclusion
criteria
utilized.
*Educators
were
available to
parents
throughout
the study.

AACN
Level of
Evidence:
Grade B
(randomized blinded
study with
consistent
results).

Limitations:
*Study could
have been
double
blinded.
*Small
sample size.
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Whiteley, P.,
Haracopos, D.,
Knivsberg, A.,
Reichelt, K.
L., Parlar, S.,
Jacobsen, J.,
Seim, A.,
Pedersen, L.,
Schondel, M.,
& Shattock, P.
(2010).
The scanbrit
randomized,
controlled,
single-blind
study of a
gluten- and
casein-free
dietary
intervention
for children
with autism
spectrum
disorders.
Nutritional
Neuroscience
13(2), 87-100.
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Purpose

Design

Sample

Data
Collection and
Measurement

Findings

Strengths
and
Limitations

Level of
Evidence

To evaluate and
compare the
effects of
dietary
intervention
between a
control and
intervention
group using a
comprehensive
assessment
battery in
children
diagnosed with
autism
spectrum
disorders.

A randomized,
controlled,
single-blind, 2stage/24 month
study using the
gluten and
casein free
diet.

Children with
autism
spectrum
disorder
diagnosis.
N=26 in the
intervention
group and
N=29 in the
control group.
Exclusion
criteria: comorbid
diagnoses of
epilepsy,
fragile-X
syndrome,
tuberous
sclerosis,
developmental
age below 24
months,
pharmacologic
therapy.

Autism
behaviors
assessed using
Autism
Diagnostic
Observation
Schedule
(ADOS) and
Gilliam Autism
Rating Scale
(GARS).
Developmental
level assessed
using Vineland
Adaptive
Behavior Scale
(VABS). Study
members
blinded.
Parents not
blinded.
Reassessments
performed at 8
and 12 months.
Control group
then placed on
diet from 12-24
months and
reassessed.

Improvement
seen after 12
months in
core autistic
behaviors for
intervention
group. ADOS
P=0.0022,
GARS
P=0.0001, as
well as
improvements
in inattention
and
hyperactivity.
Plateau effect
thereafter.

Strengths:
*Study
participants
blinded.
*Sufficient
length of
time.
*Exclusion
criteria.

AACN
Level of
Evidence:
Grade B
(randomized,
controlled
study with
consistent
results).

Limitations:
*Not double
blinded.
*Children
continued to
receive
alternative
therapies.
*Study
unable to
identify
potential best
responders.

AUTISM AND DIET
Author
(Year)
Title
Publication
Cade, R.,
Privette, M.,
Fregly, M.,
Rowland, N.,
Sun, Z., Zele,
V.,
Wagemaker,
H., &
Edelstein, C.
(2000).
Autism and
schizophrenia:
intestinal
disorders.
Nutritional
Neuroscience
3, 57-72.
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Purpose

Design

To determine
whether the
consumption
of gluten and
casein results
in an
abnormally
high level of
peptides in the
urine and
blood of
schizophrenic
adults and
autistic
children.

Cohort study.

Sample

Data
Collection
and
Measurement
N=83
Laboratory
schizophrenic tests were
men (age 17drawn from
49), N=37
subjects as
schizophrenic well as control
women (ages
subjects with
18-46), N=128 similar age
autistic boys
and sex pre(ages 3.5-16), intervention,
and N=22
at one month
autistic girls
and three
(ages 3.5-14). months after
Participants
intervention.
met DSM III
criteria for his
or her
diagnosis.

Findings

Strengths
and
Limitations

Level of
Evidence

81% of the
autistic children
showed
improvements
in laboratory
findings after
three months of
dietary
intervention.
19% showed
findings
consistent with
dietary error
and continued
gluten and
casein
consumption.
Improvement
also noted after
3 months in the
following
behaviors:
social isolation,
eye contact,
mutism,
learning skills,
hyperactivity,
stereotypical
activity,
hygiene, panic
attacks, and self
mutilation.

Strengths:
*Concrete
laboratory
findings.
*Large sample
sizes.

AACN Level
of Evidence:
Grade C
(correlational
cohort study
with
consistent
results).

Limitations:
*Short
duration.
*No control
group for
diagnosed
individuals.
*No blinding.

AUTISM AND DIET
Author
(Year)
Title
Publication
Elder, J. H.,
Shankar, M.,
Shuster, J.,
Theriaque, D.,
Burns, S., &
Sherrill, L.
(2006).
The glutenfree, caseinfree diet in
autism: results
of a
preliminary
double blind
clinical trial.
Journal of
Autism and
Developmenta
l Disorders
36(3), 413420.
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Purpose

Design

To determine
the effects of a
gluten-free,
casein-free
diet on the
behaviors of
autistic
children and
evaluate the
effects of
dietary
intervention
on urinary
peptide levels.

Randomized,
double-blind
repeated
measures
crossover
design pilot
study.

Sample

Data
Collection
and
Measurement
15 children,
Tools used to
ages 2-16 with measure
autism
subject
spectrum
qualities
disorder (12
included:
boys and 3
Autism
girls).
Diagnostic
InterviewRevised (ADIR), Childhood
Autism Rating
Scale (CARS),
Urinary
Peptide Levels
(UPL), and
Ecologic
Communicatio
n Orientation
(ECO)
Language
Sampling
Summary.
Data was
collected prior
to
intervention,
at week 6, and
at week 12.

Findings

Strengths
and
Limitations

Level of
Evidence

No significant
changes in
findings over
12 week trial
period. CARS
p=.85, ECOS
p=.29,
behavioral
frequencies
.32<p<.45,
urinary
peptide levels
of gluten
p=.44 and
casein p=.11.

Strengths:
*Randomized,
double-blind
study.
*Placebo diet
used to keep
parents
blinded.

AACN Level
of Evidence:
Grade C
(randomized
controlled
study with
inconsistent
results).

Limitations:
*Small sample
size.
*Short
duration.
*Dietary
intervention
was not in a
controlled
environment.

AUTISM AND DIET
Author
(Year)
Title
Publication
Pusponegoro,
H.D., Ismael,
S.,
Firmansyah,
A.,
Sastroasmoro,
S.,
Vandenplas,
Y. (2015).
Gluten and
casein
supplementation does not
increase
symptoms in
children with
autism
spectrum
disorder.
Acta
Paediatrica,
104, e500e505.
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Purpose

Design

To determine
the effect of
gluten and
casein
supplementation in
children who
were
previously
GFCF, on
maladaptive
behavior,
gastrointestinal symptom
severity, and
urinary IFABP
excretion.

Randomized,
double-blind,
placebo
controlled
trial.

Sample

Data
Collection
and
Measurement
50 children,
The AWPC
ages 4.3-6.7
(Approach
with ASD
Withdraw
who had
Problems
severe
Composite)
maladaptive
was used to
behavior and a measure
urinary Imaladaptive
FABP value
behaviors pre
of >
and post
96.97pg/mg
gluten and
creatinine.
casein
exposure, the
GSSI
(Gastrointestinal Symptom
Severity
Index) was
used to
measure GI
symptoms pre
and post
exposure, and
Urinary IFABP was
measured pre
and post
exposure.

Findings

Strengths
and
Limitations

Level of
Evidence

AWPC t-score
decreased after
supplementation
in placebo (p <
0.001) and
intervention
groups (p <
0.001). p=0.971
between the two
groups. Both
groups started
with a GSSI of
zero. After
intervention, the
median GSSI for
the control group
was 0 and
median for the
intervention
group was 3.
There was an
increasing trend
of I-FABP in the
intervention
group and a
decreasing trend
in the control
group, yet
changes between
the two groups
were not
significantly
different with
p=0.416.

Strengths:
*Randomized
double-blind
study.

AACN Level
of Evidence:
Grade C
(randomized
double-blind
study with
inconsistent
results).

Limitations:
*Small sample
size.
*Short duration
of gluten/casein
consumption.
*Biscuits utilized
as gluten/casein
supplementa-tion
were probably
not identical in
taste.
*Chosen amount
supplemented
was arbitrary.
*Time between
inclusion in study
and introduction
of dietary
intervention
varied.
*Outside
therapies differed
and were not
considered for
each child.

AUTISM AND DIET
Author
(Year)
Title
Publication
Harris, C.,
Card, B.
(2012).
A pilot study
to evaluate
nutritional
influences on
gastrointestinal
symptoms and
behavior
patterns in
children with
Autism
Spectrum
Disorder.
Complementary Therapies
in Medicine,
20, 437-440.
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Purpose

Design

Sample

To evaluate
the
relationship
between GI
symptoms and
behavior
patterns, and
the influence
of a GFCF
diet on these
issues in
children
diagnosed
with ASD.

Crosssectional
study.

13 children
aged 5-12
years old
diagnosed
with an ASD,
who were
recruited from
the Asperger’s
Support
Network
website.

Data
Collection
and
Measurement
Online survey
included
questions
regarding
general health,
demographics,
GI symptoms,
behavior
patterns, and a
Food
Frequency
Questionnaire
(FFQ).
Gastrointestin
al Symptoms
Rating Scale
(GSRS) was
used to rate
abnormal GI
symptoms,
and the
Childhood
Autism Rating
Scale (CARS)
was used to
rate behavior
patterns.

Findings

Strengths
and
Limitations

Level of
Evidence

More than ½ of
the children
were on a GFCF
diet by parental
choice. 53.8% of
the children
experienced post
prandial GI
symptoms.
Mean GSRS
score was 19.2
and mean CARS
score was 43.9.
Scores did not
differ according
to diet.
However, 100%
of the parents
with children on
a GFCF diet
(n=7) reported
improved GI and
behavior
patterns after
diet
implementation.

Strengths:
*Use of
validated
questionnaires.
*Relative
homogeneity
of the
sample.

AACN Level
of Evidence:
Grade C
(Crosssectional
survey study
with
inconsistent
results).

Limitations:
*Small
sample size.
*Subjective
questionnaires.
*Uncertain
ability of
parents to
quantify the
severity of
their child’s
symptoms.
*Differences
in parental
implementation of GFCF
diet.

AUTISM AND DIET
Author
(Year)
Title
Publication
Hyman, S.L.,
Stewart, P.A.,
Foley, J.,
Cain, U.,
Peck, R.,
Morris, D.D.,
Wang, H., &
Smith, T.
(2015).
The glutenfree/caseinfree diet: a
double-blind
challenge trial
in children
with autism.
Journal of
Autism and
Developmental Disorders,
46(1), 205220.
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Purpose

Design

Sample

To obtain
information
on the safety
and efficacy
of the glutenfree/caseinfree diet in
children with
Autism.

A 12-week
double-blind,
placebocontrolled
challenge
study.

14 children who
were under the
age of 6 and
diagnosed with
Autistic
Disorder,
Asperger’s
Disorder, or
Pervasive
Developmen-tal
Disorder Not
Otherwise
Specified based
on the criteria
from the
Diagnostic and
Statistical
Manual of
Mental Disorders
4th Edition.
Participants were
required to be
enrolled in a
comprehensive
Applied Behavior
Analysis
Intervention
program for the
duration of the
study.

Data
Findings
Collection
and
Measurement
Multiple scales
No
and scoring
significant
methods were
findings on
utilized to
active
include: Autism
challenge
Diagnostic
Interview (ADIdays when
R), Autism
compared to
Diagnostic
placebo
Observation
challenge
Schedule
(ADOS), Mullen days.
Scales of Early
Learning,
Vineland
Adaptive
Behavior Scales,
World Health
Organization
growth standards,
laboratory testing
for food allergies
and vitamin
deficiencies, the
Bristol Stool
Scale, the
Conners
Abbreviated
Rating Scale, and
the RitvoFreeman Real
Life Rating
Scales.

Strengths and
Limitations

Level of
Evidence

Strengths:
*Utilized
Registered
Dieticians to
monitor adherence
to diet and
nutritional intake.
*Consumption of
gluten/casein was
carefully
measured.
*Children were
receiving
consistent ABA
therapy.
*Everyone was
blinded to
challenges given.

AACN Level
of Evidence:
Grade C
(Double-blind
placebocontrolled
challenge
study with
inconsistent
results).

Limitations:
*Small sample
size.
*4-6 week
complete GFCF
diet prior to
challenges may be
too short to see
initial changes.
*Administering
gluten and/or
casein challenges
defeats purpose of
long term GFCF
diet.

AUTISM AND DIET
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Author
(Year)
Title
Publication

Purpose

Design

de Magistris, L.,
Picardi, A.,
Siniscalco, D.,
Riccio, M.P.,
Sapone, A.,
Cariello, R.,
Abbadessa, S.,
Medici, N.,
Lammers, K.M.,
Schiraldi, C.,
Iardino, P.,
Marotta, R.,
Tolone, C.,
Fasano, A.,
Pascotto, A.,
Bravaccio, C.
(2013).

To challenge
the hypothesis
that dietaryderived
nonself
antigens could
permeate
impaired gut
barrier and
stimulate the
immune
system,
affecting or
increasing
autism
symptoms.

Evaluation of
anti-body
prevalence in
study group,
control group,
and
neurotypical
group.

Antibodies
against food
antigens in
patients with
autistic spectrum
disorders.
BioMed
Research
International, 111.

Sample

Data
Collection
and
Measurement
31 children
Intestinal
with an ASD
permeability
diagnosis
measurements,
currently
antibodies to
following a
food antigens,
GFCF diet for statistical
an average of analysis using
3 years, 131
Mannchildren with
Whitney,
an ASD
Kruskaldiagnosis
Wallis and
following a
Dunn’s, and
regular diet,
Fisher exact
and 44 healthy tests.
children
utilized as
matched
controls.

Findings

Strengths
and
Limitations

Level of
Evidence

25.6% of the
enrolled ASD
children had
impaired
intestinal
barrier
function.
GFCF diet
appears to
normalize
barrier
impairment.
Immune
response is
triggered by
gluten and
casein in some
ASD children.
Determination
of antibodies
titers to food
antigens could
be used to
identify
potential
responders to
the GFCF
diet.

Strengths:
*Large sample
size of ASD
children.
*Control
groups
present.
*Concrete
laboratory
evidence
utilized.

AACN Level
of Evidence:
Grade B (Well
designed
study with
consistent
results).

Limitations:
*Smaller
control group.
*Dietary
intervention
not
professionally
monitored.
*Autism
behavior
symptoms not
evaluated.

AUTISM AND DIET
Author
(Year)
Title
Publication
Mari-Bauset, S.,
Llopis-Gonzalez,
A., Zazpe, I.,
Mari-Sanchis,
A., SuarezVarela, M.M.
(2016).
Nutritional
impact of a
gluten-free
casein-free diet
in children with
autism spectrum
disorder.
Journal of
Autism and
Developmental
Disorders, 46,
673-684.
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Purpose

Design

Sample

Data
Findings
Collection and
Measurement

Strengths
and
Limitations

Level of
Evidence

To determine
whether children
with ASD on a
GFCF diet vs. a
regular diet have
lower
anthropometric
measures, varied
nutrient intake,
and are less likely
to meet dailyrecommended
intake values.

Casecontrol
study.

Children ages
6-9 years old
diagnosed
with an ASD,
severity not
considered
(n=105).
Study group
n=20 and
control group
n=85.

Height and
weight
measurements
utilized to
calculate BMI.
Caloric intake,
macronutrients,
and
micronutrients
compared
between two
groups.
Healthy Eating
Index utilized
also to
compare
nutrients.
Dietary
Reference
Intakes utilized
to measure
adequate or
inadequate
intake.

Strengths:
*Children
presented with
similar
characteristics
in
socioeconomic
status, place of
residence,
ethnicity, and
living
conditions.
*Children
studied in
parallel over
same time
period.

AACN
Level of
Evidence:
Grade C
(Casecontrol study
with
inconsistent
results).

ASD children
on a GFCF
diet had
lower BMI’s
than those on
a regular diet.
Vitamin and
nutrient
differences
were noted
between the
two diets
with GFCF
kids being
deficient in
some
nutrients and
regular diet
kids being
deficient in
others.
Typically the
GFCF diet
group at a
“healthier”
diet than their
counterparts.

Limitations:
*Small sample
size.
*Only a 3-day
food record
was utilized.
*GFCF diet
not monitored
professionally.
*Autism
behaviors or
characteristics
not mentioned
in this study.

AUTISM AND DIET
Author
(Year)
Title
Publication
Genius, S.J. &
Lobo, R.A.
(2014).
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Design

To provide a
Caseclinical review of
report.
gluten sensitivity
as it relates to
Gluten
mental health and
sensitivity
to examine
presenting as a
pathophysiological
neuropsychiatric mechanisms for
disorder.
the
neuropsychiatric
Gastroenterology symptoms
Research and
associated with
Practice, 1-6.
gluten sensitivity
in some patients.

Sample

Data
Findings
Collection and
Measurement

A 23-year-old
female with a
longstanding
history of
auditory and
visual
hallucinations.

Symptom
review
following a
regular diet,
gluten free
diet, and after
accidental
gluten
exposure.

The subject
experienced
extreme
auditory and
visual
hallucinations
throughout her
entire life as
well as being
diagnosed
with irritable
bowel
syndrome. In
college she
decided to
independently
eliminate
gluten from
diet with
complete
resolution of
symptoms.
Symptoms
would return
within hours
of any slight
accidental
gluten
exposure and
last 24-72hrs.

Strengths
and
Limitations

Level of
Evidence

Strengths:
*Symptoms
completely
resolved after
gluten
eliminationproviding
clear
correlation.
*Subject was
not
cognitively
delayed and
able to give
accurate
description of
symptoms.

AACN
Level of
Evidence:
Grade E
(Single casereport
without
concrete
evaluation
methods).

Limitations:
*No concrete
laboratory
data utilized
as subject
refused.
*Physician
monitoring
not
mentioned.

AUTISM AND DIET
Author
(Year)
Title
Publication
Herbert, M.R.,
Buckley, J.A.
(2013).
Autism and
diet therapy:
case report
and review of
the literature.
Journal of
Child
Neurology,
28(8), 975982.
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Purpose

Design

Sample

To provide a
report of a
child who
experienced
regressive
autism at the
age of 4,
subsequently
placed on a
gluten-free
casein-free
diet, and
followed into
teenage years.

Case-report.

A 13-year-old
child who
experienced
regressive
autism at age
4 and later
diagnosed
with epilepsy
at age 11 with
limited
response to
typical
interventions.

Data
Collection
and
Measurement
The
Childhood
Autism Rating
Scale (CARS)
was utilized to
score autism
severity.
Symptoms
and
interventions
were detailed
and recorded
in
chronological
order.

Findings

Strengths
and
Limitations

Level of
Evidence

Autism
symptoms
significantly
improved on a
GFCF diet and
after puberty
seizure
activity was
significantly
improved on a
GFCF
ketogenic diet.

Strengths:
*Symptoms and
interventions are
detailed
chronologically.
*EEG performed
pre and post
further dietary
intervention.
*CARS scores
noted pre and
post
interventions.

AACN Level
of Evidence:
Grade E
(Single casereport with
unknown
source of
information).

Limitations:
*Cause of
significant
regression into
autism in a
previously
neurotypical 4year-old is not
mentioned.
*Biomedical
supplements
were also being
utilized and
changed
throughout
treatment.
*Information
source not
mentioned.

AUTISM AND DIET
Author
(Year)
Title
Publication
Genius, S.J.,
Bouchard,
T.P. (2010).
Celiac disease
presenting as
autism.
Journal of
Child
Neurology,
25(1), 114119.
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Design

To describe a Case-report.
case where a
5-year-old boy
presented with
severe autism,
later
diagnosed
with Celiac
Disease whose
autism
symptoms
resolved
following a
gluten-free
diet.

Sample

Data
Collection
and
Measurement
A 5-year-old
Symptom
boy diagnosed review and
with severe
parental report
autism at age 3 before and
who also
after dietary
experienced
interventions.
multiple
abnormal
gastrointestinal
symptoms.

Findings

Strengths
and
Limitations

Level of
Evidence

After 3
months
following a
gluten-free
diet, the child
is
mainstreamed
back into a
regular
education
classroom
without any
individualized
special
education, and
his autism
symptoms
have
disappeared.

Strengths:
*Concrete
laboratory
data utilized.

AACN Level
of Evidence:
Grade E
(Single casereport with
unknown
source of
information).

Limitations:
*Source of
information
unknown.
*Follow up
biochemical
nutritional
testing
declined by
parents due to
resolution of
symptoms.

